Company Badge
USPTO Data Jan 1 1976 - Oct 13 2026
4 Patents
#241 in Menlo Park, CA
#14,051 in California
#60,641 in US
Kedalion Therapeutics, Inc.
Forward Citations = 54
5 inventors:
Menlo Park, CA, United States of America
Kedalion Therapeutics, Inc.
Trademarks = 1
Forward Citations = 54
Loading Chart...
Loading Chart...
5 inventors (with patents filed for the assignee):
Yehuda Ivri (3 out of 50 patents)
Daniel V Palanker (2 out of 83 patents)
Mark Blumenkranz (2 out of 2 patents)
4. Ehud Ivri (1 out of 1 patent)
5. Reynaldo J Quintana (1 out of 25 patents)
4 patents:
Company Overview
Kedalion Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative ophthalmic therapies to address unmet needs in eye care. Their proprietary technologies aim to improve the treatment of various ocular diseases, including dry eye syndrome and glaucoma. With a team of experienced professionals and a commitment to scientific excellence, Kedalion Therapeutics is dedicated to advancing the field of ophthalmology.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kedalion Therapeutics, Inc.. Retrieved from https://idiyas.com/company/kedalion-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]